Radicava, Suspension zum Einnehmen

( ARTG ) RADICAVA is indicated in adults with a diagnosis of amyotrophic lateral sclerosis who are independent in activities of daily living with normal respiratory function and where treatment is initiated within two years of disease onset.,Efficacy has not been demonstrated in patients outside of this defined population.